• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

  1. Jean-Pierre Villeneuve M.D.1,*,
  2. Lynn D. Condreay2,
  3. Bernard Willems1,
  4. Gilles Pomier-Layrargues1,
  5. Daphna Fenyves1,
  6. Marc Bilodeau1,
  7. Raymond Leduc1,
  8. Kevork Peltekian3,
  9. Florence Wong4,
  10. Mariana Margulies4,
  11. E. Jenny Heathcote4

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510310130

Issue

Hepatology

Hepatology

Volume 31, Issue 1, pages 207–210, January 2000

Additional Information

How to Cite

Villeneuve, J.-P., Condreay, L. D., Willems, B., Pomier-Layrargues, G., Fenyves, D., Bilodeau, M., Leduc, R., Peltekian, K., Wong, F., Margulies, M. and Heathcote, E. J. (2000), Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology, 31: 207–210. doi: 10.1002/hep.510310130

Author Information

  1. 1

    Division of Hepatology, Centre Hospitalier de l'Université de Montréal, Montréal, Canada

  2. 2

    Glaxo Wellcome Inc, Durham, NC

  3. 3

    Division of Gastroenterology, Queen Elisabeth II Health Sciences Center, Dalhousie University, Halifax, Canada

  4. 4

    Division of Gastroenterology, The Toronto Hospital, University of Toronto, Toronto, Canada

*Centre de recherche du, Centre Hospitalier de l'Université de Montréal, Hôpital Saint-Luc, 264, boul. René-Lévesque est, Montréal, Québec, Canada, H2X 1P1. fax: (514) 281-2492

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003
  3. Manuscript Accepted: 14 OCT 1999
  4. Manuscript Received: 23 JUN 1999

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (90K)

References

  • 1
    DeJongh FE, Janssen HLA, DeMan LA, Hop WCJ, Schalm SW, Van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103:1630–1635.MEDLINE
  • 2
    Nevens F, Goubau P, Van Eyken P, Desmyter J, Desmet V, Fevery J. Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha. Liver 1993; 13:15–19.MEDLINE
  • 3
    Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Interferon alpha for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104:1116–1121.MEDLINE
  • 4
    Perillo R, Tamburro C, Regenstein F, Bolart L, Bodenheimer H, Silva M, Schiff E, et al. Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology 1995; 109:908–916.MEDLINE
  • 5
    Marcellin P, Giuily N, Loriot MA, Durand F, Samuel D, Bettan L, Degott C, et al. Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis. J Viral Hepatitis 1997; 4(suppl 1):21–26.
    Direct Link:
  • 6
    Dienstag JL, Perillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:1657–1661.MEDLINE
  • 7
    Nevens F, Main F, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, Fevery J, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 1997; 113:1258–1263.MEDLINE
  • 8
    Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339:61–68.MEDLINE
  • 9
    Perillo R, Rakela J, Martin P, Wright T, Levy G, Schiff E, Dienstag J, et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT) [Abstract]. Hepatology 26:61–68.
  • 10
    Van Thiel DH, Friedland L, Kania RJ, Molloy PJ, Hassaneim E, Faruki H. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B. Hepato-Gastroenterology 1997; 44:808–812.
  • 11
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646–649.MEDLINE
    Direct Link:
  • 12
    Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998; 27:628–633.MEDLINE
    Direct Link:
  • 13
    Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Kato J, Carilloho FJ, et al. Susceptibility of lamivudine resistant hepatitis B virus to other antivirals: adefovir and lobucavir. Hepatology 1998; 28:165A.
Get PDF (90K)